Medipharm Laboratories

MediPharm Labs is a specialized pharmaceutical company focused on the development and manufacture of pharma-grade cannabinoid APIs and finished products. Operating as a Contract Development and Manufacturing Organization (CDMO), the company provides extraction, purification, and formulation services under strict Good Manufacturing Practice (GMP) standards. With facilities in Canada and Australia, MediPharm serves the global medical and wellness markets with high-purity oils, isolates, and distillates. The company also develops its own branded products and supports clinical trials for cannabinoid-based therapies. Following its acquisition of VIVO Cannabis, the company has expanded its portfolio to include medical cannabis flower and patient-focused services.